4
Changes in Ownership
ADMA BIOLOGICS, INC. Filed Acc 0001140361-25-026099
President and CEO sold 21,000 shares at $18.66 ($391,860)
- President and CEO acquired 15,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Grossman Adam S · President and CEO
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-07-15 | Exercise or conversion : show line 1 in the form 10b5-1 | +15,000 | $5.40 | $81,000 | 2,058,850 | D |
| 2025-07-15 | Sale : show line 2 in the form 10b5-1 | −15,000 | $18.66 | $279,900 | 2,043,850 | D |
| 2025-07-15 | Sale : show line 3 in the form 10b5-1 | −6,000 | $18.66 | $111,960 | 2,037,850 | D |
| Open-market sales · 21,000 sh · avg $18.66 · $391,860 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-07-15 | Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (right to buy) | −15,000 | 795,950 | D |
Loading xslF345X05/form4.xml…